At what enterprise value was VIVALTO SANTÉ acquired in 2021?

During the acquisition of VIVALTO SANTÉ by VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT in 2021, the transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR.

What was the EV/EBITDA of VIVALTO SANTÉ when it was acquired by VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT?

The estimated EV/EBITDA multiple for VIVALTO SANTÉ is in the range of 10x - 18x.

What was the revenue of VIVALTO SANTÉ at the time of the deal?

The revenue of VIVALTO SANTÉ at the time of the deal is estimated to be in the range of 750M - 1.3b EUR.

What was the EBITDA of VIVALTO SANTÉ during the acquisition?

VIVALTO SANTÉ's EBITDA is estimated to be in the range of 100M - 200M EUR.

How is the data for the VIVALTO SANTÉ acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the VIVALTO SANTÉ deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/le-nouveau-tour-de-table-de-vivalto-sante-est-en-place-1369518

← DATABASE

Home Database Healthcare & PharmaVIVALTO SANTÉ

12/2021

VIVALTO SANTÉ acquired by VIVALTO PARTNERS, IK PARTNERS, MACSF, ARKEA CAPITAL & BNP PARIBAS DEVELOPPEMENT

FRANCE Health Providers / Healthcare Facilities / Clinics / Hospitals EV 1b - 4b EUR

Context

Vivalto Santé completed its third LBO, with Vivalto Partners — Daniel Caille's newly created investment management vehicle — taking control of the group. IK Partners joined as a key new minority shareholder alongside a broad consortium of reinvesting French institutional investors and the Bpifrance-Mubadala sovereign duo. The transaction is notably characterised by a strong medical and employee shareholder component, with approximately 1,000 physicians and ultimately 35% of employees targeted as co-investors. The financing structure comprises a Term Loan B and a revolving credit facility, supplemented by subordinated instruments arranged by Hayfin.

As a reminder, Vivalto Santé had previously acquired Mathilde MéDical DéVeloppement in 2020 as part of its expansion strategy.

VIVALTO SANTÉ, which reported an EBITDA margin of in 2021, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Vivalto Santé is a leading French private hospital and clinic group, founded in 2009 by Daniel Caille and a group of physicians, operating under a distinctive "third way" governance model that associates medical professionals and financial investors under a shared ownership and decision-making structure. The group has grown rapidly through an active acquisition strategy.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2021

2020

Other operations with VIVALTO SANTÉ

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
01/2020	VIVALTO SANTÉ	MATHILDE MÉDICAL DÉVELOPPEMENT	FRANCE	Clinics / Hospitals

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 750M - 1.3b EUR

EBITDA range: 100M - 200M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VIVALTO SANTÉ by VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: vivalto santé

Acquirer: vivalto partners / ik partners / bnp paribas developpement / macsf / arkea capital